David Burgoyne, Ph.D.

David Burgoyne, Ph.D.

Founder and CEO

Dr. David Burgoyne has over 20 years of experience in the business of drug discovery and early stage pharmaceutical development.

    John Langlands, Ph.D.

    John Langlands, Ph.D.

    Vice President Pre-Clinical Research

    Joining Naegis in the summer of 2013, Dr. John Langlands brings over 20 years of experience in the development of new pharmaceuticals.

      Dr. Peter Hnik, MD, MHSc

      Dr. Peter Hnik, MD, MHSc

      Clinical Advisor

      Dr. Peter Hnik received his medical degree from the Medical Faculty of Charles University of Prague in 1981.

        Tim Fernback

        Tim Fernback

        Finance and Business Development, Advisor

        Tim has over 25 years of finance experience as a director and officer of public and private technology, natural resources, health and biosciences comp

          Erin DeBruin, Ph.D.

          Erin DeBruin, Ph.D.

          Director of Biology

          After completing her BASc. in Chemical Engineering, Dr. Erin DeBruin obtained her Ph.D. in Experimental Medicine at UBC specializing in mouse models o

            James Yee, Ph.D.

            James Yee, Ph.D.

            Director of Chemistry

            Dr. Yee completed his doctoral studies in synthetic organic chemistry at the University of British Columbia with Edward Piers.

              123111213
              Top
              We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…